Co-amoxiclav
Co-amoxiclav is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)
Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite
Preschool Wheeze: Inflammation/Infection Guided Management
Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery
The Amputation Surgical Site Infection Trial (ASSIT)
Clinical Trials (9)
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)
Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite
Preschool Wheeze: Inflammation/Infection Guided Management
Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery
The Amputation Surgical Site Infection Trial (ASSIT)
Does Antibiotics Use During Surgery Help to Decrease Wound Infection and Increase Success After Ear Surgery in Children
Prophylaxis Of Wound Infections- Antibiotics in Renal Donation
Antibiotic Prophylaxis for PEG in Children
Antibiotics for the Treatment of Ulcerative Colitis
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9